External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home APVRS 2026
Roche and Genentech at

APVRS 2026

August 28 - August 30
Gold Coast, Australia
2026.apvrs.org
We will be contributing to topics related to
Ophthalmology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
06:20 AM
Duration 5mins Gold Coast, Australia
Effectiveness and Safety of Faricimab▼ in Eyes With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (nAMD) Over 2 Years: Results From the UK Faricimab Real-World Evidence (FARWIDE) Study
Kenneth Fong, Sobha Sivaprasad, Tunde Peto, Rhianon Reynolds, Clare Bailey, Louise Downey, Ian Pearce, Christine Kiire, Gabriella de Salvo, Deepali Varma, James Talks, Praveen J. Patel, Samantha R. de Silva, Richard P. Gale, Martin McKibbin, Gloria C. Chi, Abigail Darnell, Amanda Downey, Melanie Dodds, Parul Dayal
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 AM
Duration 5mins Gold Coast, Australia
Better Visual Outcomes With Faricimab▼ vs Aflibercept 2 mg in Patients With Treatment-Naïve Neovascular Age-Related Macular Degeneration (nAMD) Who Had Small Lesions: A TENAYA/LUCERNE Post Hoc Analysis
De-Kuang Hwang, Amer Omar, Eric Nudleman, Nicholas Dagincourt, Florie Mar, Shriji Patel, Philippe Margaron
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:05 AM
Duration 5mins Gold Coast, Australia
Faricimab▼ for Polypoidal Choroidal Vasculopathy (PCV): Two-Year Results From the SALWEEN Trial
Gemmy Cheung, Timothy Y. Y. Lai, Shih-Jen Chen, Shigeru Honda, Adrian Hock Chuan Koh, Won Ki Lee, Xiaorong Li, Paisan Ruamviboonsuk, Min Sagong, Xiaodong Sun, Yasuo Yanagi, Ruobing Bai, Xiaoying Yang, Philippe Margaron
Ophthalmology | Neovascular Age Related Macular Degeneration - Polypoidal Choroidal Vasculopathy

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
07:30 AM
Duration 60mins Gold Coast, Australia
View: the APVRS symposium "LOOKING BEYOND INJECTIONS: Addressing the treatment challenge of nAMD"
Andrew Chang, I-van Ho, Yi-Ting Hsieh , Nancy Holekamp
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:33 PM
Duration 3mins Gold Coast, Australia
One-Year Outcomes of Faricimab▼ Patients With Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) From a Global, Prospective Observational Study: The VOYAGER Study
Robyn Guymer, Aires Lobo, Clare Bailey, Voraporn Chaikitmongkol, Varun Chaudhary, Gloria C. Chi, Robert P. Finger, Susumu Ishida, Adrian Hock Chuan Koh, Monica Lövestam-Adrian, Jose D. Luna Pinto, Steffen Schmitz-Valckenberg, Diane Uschner, Jörn Schweitzer, Veeral Sheth, Eric H. Souied
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:00 PM
Duration 3mins Gold Coast, Australia
Anatomical Outcomes Of Faricimab▼ In Patients With Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME): 6-month Real-world Imaging From The VOYAGER Study
Adrian Hock Chuan Koh, Robert P. Finger, Susumu Ishida, Steffen Schmitz-Valckenberg, Mariacristina Parravano, Clare Bailey, Voraporn Chaikitmongkol, Varun Chaudhary, Nripun Sredar, Gloria C. Chi, Amanda Downey, Thomas Albrecht, Diane Uschner, Monica Lövestam-Adrian, Jose D. Luna Pinto, Jörn Schweitzer, Veeral Sheth, Eric H. Souied, Robyn Guymer
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:21 AM
Duration 3mins Gold Coast, Australia
Impact of Baseline Subretinal Fluid (SRF) on Treatment Outcomes in Diabetic Macular Edema (DME): Analysis of the Phase 3 YOSEMITE and RHINE Trials
Jeeyun Ahn, Rolake Alabi, Lei Han, Alexandra Warter, Manuel Amador, Kara Gibson
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:33 AM
Duration 3mins Gold Coast, Australia
Reduction in Subretinal Hyperreflective Material (SHRM) With Faricimab▼ vs Aflibercept 2 mg in Treatment-Naïve Neovascular Age-related Macular Degeneration (nAMD)
Se Joon Woo, Sean Adrean, Srinivas Sadda, Jesse Jung, Isabel Bachmeier, Anh Nguyen Duc, Lei Han, Andreas Maunz, Shriji Patel, Siqing Yu, Philippe Margaron
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:35 PM
Duration 5mins Gold Coast, Australia
Efficacy and Safety of Vamikibart in Patients With Uveitic Macular Edema: Pooled Results from the Phase 3 MEERKAT and SANDCAT Trials
Lyndell L. Lim, Glenn J. Jaffe, Eric B. Suhler, Rahul N. Khurana, Carlos Pavesio, Koh-Hei Sonoda, Mark Lomax, Deanna Galloway, Emma Harrell, Marina Mesquida, Zdenka Haskova, David Silverman, Ivo Stoilov, André Vicente, Laura Steeples, Nisha Acharya
Ophthalmology | Uveitic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Gold Coast, Australia
A Synthesis of Real‑World Evidence From the J‑CAT Studies: Treatment Patterns, Complication/Adverse Event Risks, and Economic Burden in Non‑Infectious Uveitis (NIU) in Japan
Sentaro Kusuhara, Koh-Hei Sonoda, Toshikatsu Kaburaki, Tachie Fujita, Saki Katayama, Mariko Nio, Takao Nakamura,Takashi Omoto, Yukari Matsuo-Tezuka, Misako Makishima, Tomoki Yoshizaki, Yuji Fujisawa, Mio Kitamura, Kensuke Sasaki, Kairi Ri, Keiko Sato,Hiroshi Goto
Ophthalmology | Uveitis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:18 AM
Duration 3mins Gold Coast, Australia
Improved Vascular Stability Biomarkers With Faricimab▼ Vs Aflibercept 2 mg Using Automated Quantification On Ultra-Widefield Fluorescein Angiography (UWFA), Color Fundus Photography (CFP) and Optical Coherence Tomography (OCT)
Hemal Mehta, Murtaza Adam, Justis P. Ehlers, Andreas Pollreisz, Prethy Rao, Colin S. Tan, Gavin S. Tan, Thomas Albrecht, Manuel Amador, Fethallah Benmansour, Florie A. Mar, Dawn A. Sim, Ming Yang, and Kara Gibson
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.